Crinetics Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an…

Biotechnology
US, San Diego [HQ]

News

Theses · Events · Sentiments
Sentiments
25-01-02 35.80%

Crinetics Pharmaceuticals is currently overvalued but holds strong Wall Street support with a $75.07 average price target, indicating a 47.43% …

End of CRNX's Analysis
CIK: 1658247 CUSIP: 22663K107 ISIN: US22663K1079 LEI: - UEI: -
Secondary Listings
CRNX has no secondary listings inside our databases.